Vaccine against H1N1 flu to be produced in Dresden
epa01761912 An employee of pharmaceutical company 'GlaxoSmithKline' presents a probe filled with H1N1 flu viruses shortly before injecting them into chicken eggs at a high security laboratory in Dresden, Germany, 15 June 2009. Pharmaceutical company 'Novartis' has begun to produce the vaccine at its plant in Marburg and production is set to begin at 'GlaxoSmithKline' in Dresden in the following week. According to information by producers, it would take months to successfully develop, license and produce a vaccine, even under ideal conditions. Two vaccinations would furthermore be needed to provide full protection because the virus was of a totally new type. After the development process 4,9 billion single vaccine doses could be produced worldwide. EPA/RALF HIRSCHBERGER
Not available for distribution, sale, or license by Corbis' international representatives.
Not available for use by the following France publications: L'Express, Le Point, Marianne, Paris Match, Nouvel Observateur, VSD, Expansion, Capital and Entreprendre.
Available for license and invoicing to customers located in the United States, Canada, the United Kingdom, Ireland, France, Macau, and Australia.
Content not available for subscription distribution.
Uncompressed file sizes and pixel dimensions are approximate. Grayscale images are 1/3 the file size of RGB files. Files downloaded directly from the website are compressed JPEG format. You may request a TIFF file, if available, or a larger interpolated size for your output needs. Please contact Customer Service for associated production fees.